GAA
DGX icon

Global Assets Advisory’s Quest Diagnostics DGX Stock Holding History

Global Assets Advisory’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,729
Closed -$270K – 133
2022
Q4 		$270K Buy
1,729
+85
+5% +$12.2K 0.29% 94
2022
Q3 		$236K Sell
1,644
-1,431
-47% -$188K 0.24% 112
2022
Q2 		$418K Buy
+3,075
New +$419K 0.9% 29

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Assets Advisory's DGX Position: Q1 2023 in Review

Global Assets Advisory sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 1,729 shares — an estimated $270K sold.

Global Assets Advisory first reported a position in DGX in Q2 2022 and held it in 3 quarters. The position peaked at $418K in Q2 2022. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Global Assets Advisory reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Global Assets Advisory sold 1,729 Quest Diagnostics shares in Q1 2023, an estimated $270K.
  • Global Assets Advisory first reported a position in Quest Diagnostics in Q2 2022 and held it in 3 quarters.
  • Global Assets Advisory's Quest Diagnostics position peaked at $418K in Q2 2022.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Global Assets Advisory's 13F filing for Q1 2023, filed 21 Apr 2023.